company background image
603716 logo

Thalys Medical Technology Group SHSE:603716 Stock Report

Last Price

CN¥8.58

Market Cap

CN¥1.5b

7D

16.3%

1Y

41.1%

Updated

07 Feb, 2025

Data

Company Financials

Thalys Medical Technology Group Corporation

SHSE:603716 Stock Report

Market Cap: CN¥1.5b

603716 Stock Overview

Provides intensive operation services of medical inspection in China. More details

603716 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Thalys Medical Technology Group Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Thalys Medical Technology Group
Historical stock prices
Current Share PriceCN¥8.58
52 Week HighCN¥11.59
52 Week LowCN¥5.13
Beta0.76
1 Month Change23.45%
3 Month Change14.86%
1 Year Change41.12%
3 Year Change-38.45%
5 Year Change-51.74%
Change since IPO-22.50%

Recent News & Updates

Revenues Working Against Thalys Medical Technology Group Corporation's (SHSE:603716) Share Price Following 30% Dive

Jan 08
Revenues Working Against Thalys Medical Technology Group Corporation's (SHSE:603716) Share Price Following 30% Dive

Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth

Nov 20
Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth

Recent updates

Revenues Working Against Thalys Medical Technology Group Corporation's (SHSE:603716) Share Price Following 30% Dive

Jan 08
Revenues Working Against Thalys Medical Technology Group Corporation's (SHSE:603716) Share Price Following 30% Dive

Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth

Nov 20
Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth

Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Aug 12
Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Shareholder Returns

603716CN BiotechsCN Market
7D16.3%1.9%1.9%
1Y41.1%-11.8%17.4%

Return vs Industry: 603716 exceeded the CN Biotechs industry which returned -11.8% over the past year.

Return vs Market: 603716 exceeded the CN Market which returned 17.4% over the past year.

Price Volatility

Is 603716's price volatile compared to industry and market?
603716 volatility
603716 Average Weekly Movement11.2%
Biotechs Industry Average Movement5.4%
Market Average Movement6.6%
10% most volatile stocks in CN Market10.7%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 603716's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 603716's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20041,406Zheng Wangwww.thalys.net.cn

Thalys Medical Technology Group Corporation provides intensive operation services of medical inspection in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

Thalys Medical Technology Group Corporation Fundamentals Summary

How do Thalys Medical Technology Group's earnings and revenue compare to its market cap?
603716 fundamental statistics
Market capCN¥1.46b
Earnings (TTM)-CN¥210.78m
Revenue (TTM)CN¥1.90b

0.8x

P/S Ratio

-7.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603716 income statement (TTM)
RevenueCN¥1.90b
Cost of RevenueCN¥1.54b
Gross ProfitCN¥357.14m
Other ExpensesCN¥567.92m
Earnings-CN¥210.78m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Apr 29, 2025

Earnings per share (EPS)-1.13
Gross Margin18.83%
Net Profit Margin-11.11%
Debt/Equity Ratio96.1%

How did 603716 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 11:36
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Thalys Medical Technology Group Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yin YePing An Securities Co. Ltd.